Malaria vaccine design: immunological considerations.
Good
Michael F
MF
Division of Immunology, The Queensland Institute of Medical Research, Brisbane, QLD 4006, Australia. michael.good@griffith.edu.au
Doolan
Denise L
DL
D000818:Animals; D000953:Antigens, Protozoan / Q000276:immunology; D018414:CD8-Positive T-Lymphocytes / Q000276:immunology; D015195:Drug Design; D006801:Humans; D057131:Immune Evasion; D017780:Malaria Vaccines / Q000276:immunology*; D010961:Plasmodium / Q000276:immunology; D019444:Vaccines, DNA / Q000276:immunology; D022223:Vaccines, Subunit / Q000276:immunology; D014614:Vaccines, Synthetic / Q000276:immunology
D000953:Antigens, Protozoan; D017780:Malaria Vaccines; D019444:Vaccines, DNA; D022223:Vaccines, Subunit; D014614:Vaccines, Synthetic